Cancer Clinical Trials in the Era of COVID and Precision Medicine

Learning Objectives:

• Define the impact of COVID cancer care and trials.
• Illustrate the role of molecular profiling in cancer care and trial decisions.
• Recognize the ability to use the cancer's biology in guiding care.

Howard "Skip A. Burris, III, M.D.
Chief Medical Officer, Sarah Cannon Research Institute

Executive Director, Drug Development; President, Clinical Operations, Sarah Cannon Research Institute, Nashville, TN

LOCATION  Virtually via Zoom

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

ABOUT Cancer Center Grand Rounds are held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.

ADDITIONAL INFORMATION Light refreshments will be served on the Phoenix campus only.

ARCHIVED PRESENTATIONS Located in Arizona Cancer Center Grand Rounds Video Library

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.